BIOLASE Announces Pricing of $1.4 Million Registered Direct Offering
Dentistry Today
DECEMBER 7, 2023
million of its common stock and pre-funded warrants in a registered direct offering, and warrants to purchase common stock in a concurrent private placement, priced at the market under Nasdaq rules. BIOLASE, Waterlase, and Waterlase iPlus are registered trademarks of BIOLASE, Inc. The warrants will have an exercise price of $1.23
Let's personalize your content